4-chlorokynurenine

Known as: Benzenebutanoic acid, alpha,2-diamino-4-chloro-gamma-oxo-, (+-)- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2018
0119952018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Traditional pharmacological treatments for depression have a delayed therapeutic onset, ranging from several weeks to months, and… (More)
Is this relevant?
2015
2015
Currently approved antidepressant drug treatment typically takes several weeks to be effective. The noncompetitive N-methyl-d… (More)
Is this relevant?
2007
2007
Kynurenic acid (KYNA) is an endogenous NMDA receptor antagonist as well as a blocker of the alpha7* nicotinic receptor and… (More)
Is this relevant?
2005
2005
PURPOSE The tryptophan metabolite kynurenic acid (KYNA) and its synthetic derivative, 7-chlorokynurenic acid (7-Cl-KYNA), are… (More)
Is this relevant?
2000
2000
The synthetic compound 4-chlorokynurenine has been shown to be enzymatically transaminated to the selective glycine(B) receptor… (More)
Is this relevant?
1996
1996
7-Chlorokynurenic acid (7-Cl-KYNA) and 5,7-dichlorokynurenic acid (5,7-Cl2-KYNA) are of therapeutic interest as potent glycine/N… (More)
Is this relevant?
1995
1995
The metabolism of L-tryptophan to the neuroactive kynurenine pathway metabolites, L-kynurenine, kynurenate and quinolinate, and… (More)
Is this relevant?